Borghaei H, Smith M, Millenson M, Shafer D, Thibodeau L, Schilder R
Phase I trial of combination therapy with Y-90 ibritumomab tiuxetan and gemcitabine in patients with non-Hodgkin is lymphoma
Blood. 2006 Nov;108(11):260B-260B.
Abstract